Science Lab

WHO WE ARE

Matica Biotechnology, Inc. is a contract development and manufacturing organization (CDMO) specializing in the production of virus-based cell & gene therapeutics, oncolytic vectors and vaccines for our clients. Supported by our parent company, CHA Biotech, our new GMP facility in College Station, TX provides comprehensive support for your virus products including:

  • GMP Production in Suspension and Microcarrier Platforms

  • QC Release and Stability Testing

  • Process Development and Scale-up

  • Assay Development and Phase-appropriate Validation

  • Cell and Virus Banking

Our LENTIVIRUS and AAV manufacturing platforms have been designed to streamline the CMC development cycle by optimizing biological components, processes and documentation to maximize titers, minimize impurities, and mitigate technical and regulatory risks.

To provide our clients with world-class innovative manufacturing solutions designed to accelerate the delivery of advanced cell and gene therapies from idea to patient.

MISSION

We are establishing a global multi-facility network purpose-built for the production of cell- and virus-vectored therapies and vaccines.

Our technical platforms and manufacturing operations will be designed to stream-line the development and manufacturing cycles to support the biopharmaceutical industry’s need for faster delivery of viral vectors without sacrificing quality or safety.

VISION

 
 

OUR SERVICES

project management flow.png

Our experts work hand-in-hand with your team guiding your project from technology transfer through to production and release of the final product. Throughout the lifetime of your program, a dedicated Project Manager is assigned to manage each activity step by step.

  • Clonal selection and growth parameters

  • adaptation to suspension-based growth

  • Media screening and cell culture optimization

  • Cell banking

View More >>

  • Clonal selection and growth parameters

  • Adaption to suspension-based growth

  • Media screening and cell culture optimization

  • Cell banking

CELL LINE

DEVELOPMENT

for client-provided cell lines

PROCESS

DEVELOPMENT

  • Vector rescue & development

  • Plasmid transfection efficiencies

  • Bioreactor parameter optimization

  • Improved product profiles

  • Streamlined scale-up & transfer to GMP production

View More >>

ASSAY DEVELOPMENT

& VALIDATION

  • Method transfer, development & optimization

  • Phase-appropriate validation & transfer to QC testing lab

  • Development of GMP grade bill of materials and raw materials testing program

View More >>

GMP

PRODUCTION

  • Full utilization of single-use technologies

  • Suspension-based production at <50L and 500L scale

  • Purification utilizing large-scale filtration and chromatographic unit operations

View More >>

PRODUCT RELEASE

& STABILITY TESTING

  • Viral particle titers

  • Infectivity assays

  • Molecular assays

  • Immunoassays

  • Sterility analyses

  • ICH stability chambers

View More >>

MANUFACTURING CYCLE

Clipboard

Technology Transfer

To transfer current process protocols and data (if any) to begin assessment and development of your project.

To establish development & manufacturing plan.

INPUT

  • Client Supplied Process Information

  • Biological Starting Materials

  • Matica Bio Platform

DELIVERABLES

  • Confirmed SOW

  • Project Gantt Chart

  • Tech Transfer Protocols

 
 
 
Business Meeting

MANAGEMENT

President & CEO

Chief Manufacturing Officer

Chief Technical Officer

Chief Commercial Officer

Sr Director of

Quality & Regulatory Affairs

Founder & Advisor

Founder & Advisor

Newspaper

NEWS

NEWS  |  05.12.2021

Westinghouse Building (source).jpg

Matica Biotechnology, Inc. Appoints Yun Jeong Song as new CEO

NEWS  |  03.2021

collaboration logo (JPG).jpg

Matica Biotechnology, Inc.

Announces Master Research Agreement with Texas A&M

NEWS  |  02.2021

21005_0357_edited.jpg

Matica Biotechnology, Inc.

Announces Groundbreaking for 

a New GMP Facility